Form 4: Korro Bio Insider Sells Shares for Tax Withholding

Korro Bio's General Counsel, Jeffrey Cerio, reported a transaction involving the sale of 6,609 shares of common stock to cover tax obligations related to restricted stock units.

Summary

• Jeffrey Cerio, General Counsel at Korro Bio, Inc., engaged in a transaction on June 16, 2026.
• The transaction involved the sale of 6,609 shares of common stock.
• These shares were sold to satisfy mandatory tax withholding obligations upon the vesting and settlement of restricted stock units (RSUs).
• The sale was executed under a Rule 10b5-1(c) plan, indicating it was pre-planned.
• The weighted-average sale price was $10.83 per share, with individual sales ranging from $10.58 to $11.35.
• Following this transaction, Cerio beneficially owns 35,293 shares of common stock.
• This ownership includes 20,951 shares from an RSU that is scheduled to vest on December 15, 2026, contingent on continued employment.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale is a standard procedure for covering tax obligations on vested equity awards and is executed under a pre-arranged plan.

Positives

• The sale was conducted under a Rule 10b5-1(c) plan, suggesting a pre-arranged and compliant trading strategy.
• The transaction directly addresses tax liabilities arising from RSU vesting, a standard and necessary corporate event.
• Jeffrey Cerio continues to hold a significant number of shares (35,293), including unvested RSUs, indicating continued commitment to the company.

Negatives

• An insider sale, even for tax purposes, can sometimes be perceived negatively by the market, although this specific sale is routine.
• The sale reduces the immediate beneficial ownership of a key executive.

Risks

• The unvested RSU of 20,951 shares is subject to forfeiture if the reporting person does not maintain continuous service through December 15, 2026.
• While not explicitly stated as a risk in this filing, insider selling can sometimes signal a lack of confidence in future stock performance, though this is a tax-related sale.

Future Outlook

The filing indicates that 20,951 shares of common stock are issuable upon settlement of an RSU that will vest on December 15, 2026, subject to continued service.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding purposes are common events for executives holding restricted stock units or options, especially following significant vesting periods. This type of transaction is generally considered routine and not indicative of a negative outlook on the company's prospects.

Stakeholder Impact

• Shareholders: The sale is a routine tax-related event and is unlikely to have a significant direct impact on the share price. The continued holding of shares by management is a positive signal.
• Employees: This transaction highlights the equity compensation structure and its tax implications for executives.
• Management: Jeffrey Cerio is managing his tax liabilities related to equity compensation.

Next Steps

• Vesting of 20,951 RSUs on December 15, 2026, contingent on continued service.
• Potential future sales by Jeffrey Cerio to cover tax obligations on further RSU vesting or other equity awards.

Key Dates

Keywords

Korro Bio, KRRO, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Tax Withholding, Beneficial Ownership, Securities Exchange Act, Rule 10b5-1